Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
A to Z Index
Follow FDA
FDA Voice Blog
Enter Search terms
Most Popular Searches
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
11/29/2007
Trade Name:
Triesence 40mg/mL
Generic Name or Proper Name (*):
triamcinolone acetonide injectable suspension
Indications Studied:
Visualization during vitrectomy
Label Changes Summary:
* Efficacy and safety of corticosteroids in the pediatric population are based on the well-established course of effect of corticosteroids, which is similar in pediatric and adult populations * Adverse effects of corticosteroids in pediatric patients are similar to those in adults * New indication
Product Labeling:
Labeling
PREA(P):
P
Sponsor:
Alcon Research, Ltd.
NNPS:
TRUE
Therapeutic Category:
Anti-inflammatory, topical
-
-